US

MedMen Enterprises Inc (CSE:MMEN) is going through a lot of turmoil these days. Not only is The Company burning through lots of cash and is facing a lawsuit from its ex-CFO, but now it's seeing some important members of its team depart.

There is a big bill circulating the U.S. government that could have a big impact on the cannabis industry. The Strengthening the Tenth Amendment Through Entrusting States (STATES) Act could lead to significant opportunities in the U.S. It could help open the door to more consolidation of U.S. and Canadian operations and lead to more mergers and acquisitions. Here are five companies to watch for if the bill passes.

April 20, aka 4/20, is coming up and one way cannabis enthusiasts can celebrate it is with a CBD-infused burger from fast-food chain Carl's Jr. According to the Company, it has enough supply to be able to sell at least 1,000 burgers containing CBD.

MedMen Enterprises Inc (CSE:MMEN) announces preliminary results for Q3 which included sales up until March 30.

On April 18, investors will have the opportunity to invest in a new marijuana ETF, the first that focuses on U.S. pot stocks.

As many as 212,000 medical marijuana patients are registered in the State of Florida. It is one of the biggest markets in the U.S. and it could have even more explosive growth if patients could have help in covering the cost of cannabis.

The State of Colorado recently updated its sales numbers for cannabis, and they're continuing to slide. With $119 million in sales for February, it was the lowest month that the State had since February of last year when it earned $113 million. It was also the second consecutive month that total cannabis sales were down.

Mike Tyson launched his marijuana products with Nevada-based Plant 13 Holdings Inc (CSE:PLTH), where they would be the exclusive launch partner for his products in the State.

With financings abound, we provide an update on the expansion plans of some of the most ambitious vertically integrated cannabis companies.

Attorney General William Barr is taking a much softer stance on marijuana that Jeff Sessions ever did. While he might not be pushing for marijuana legalization, he's not happy with where things are now and would prefer to leave it up to individual States to make rules that work for them.

Unilever (NYSE:UN) is a massive consumer goods company. It hasn't acquired a cannabis company and it's not about to start growing its own pot, but one of its subsidiary companies is looking to sell CBD-infused deodorant products

Trulieve Cannabis Corp (CSE:TRUL) released its fourth-quarter earnings on Wednesday, with sales for the quarter totalling more than $35.9 million, increasing by 172% year over year. For all of 2018, its sales were $103 million - five times what Trulieve recorded in 2017.

Oregon has a marijuana supply problem. According to a report from the Oregon Liquor Control Commission, updated on March 2, there is nearly 1.2 million pounds of marijuana inventory sitting in the State in what it calls "usable marijuana."

On October 17, Canada legalized the recreational cannabis market. However, one key segment of the market that it did not include in the legislation was edibles. All we know is that by October 17 of this year or earlier, Canada is going to legalize edibles. But when that happens is still unclear.

Cannabis and food go hand in hand. Even a girl scout in California has realized how big of a business it is to sell food outside of a dispensary. It's no wonder restaurant Chefs see cannabis-infused foods as the next big trend for 2019.

It's been an odd few weeks for pot stocks where we've seen some big names struggle, while smaller companies have been on the rise.

Five companies in the world of cannabis retail and the progress they've been making thus far.

U.S. cannabis companies are at a big disadvantage to their Canadian counterparts when it comes to banking. The good news is that there is progress finally being made on the issue. Recently, the House Financial Services Committee voted in favor of passing a cannabis banking bill that would help reform the industry.

Stocks listed on the Canadian Securities Exchange (CSE) are typically seen as higher risk than their TSX-listed counterparts. However, when it comes to pot stocks, those that are on the CSE also present a lot more opportunity.

Marijuana bills across the US made significant progress in various parts of the country. Is more to come?

Lab-made marijuana? Recently, at the University of California in Berkeley, scientists were able to create cannabis compounds without needing to use a plant to harvest them.

Orchid Ventures, Inc. (CSE:ORCD) is one of the newest pot stocks to hit the Canadian Securities Exchange (CSE). The California-based company began trading on the CSE on March 18 of this year. And in less than a month of being listed, the stock price has already risen by more than 70%. Is more to come?

Colorado Governor Jared Polis signed a bill that would allow medical marijuana use to be expanded to include autism as a qualifying medical condition.

Last week, Charlotte's Web Holdings, Inc. (CSE:CWEB)(OTCQX:CWBHF) released its year-end results, which continued to show a lot of growth. The Company's sales reached $21.5 million for the three months ending December 31. This is an increase in Charlotte's Web's top line by more than 70% from the previous year.

As marijuana legalization has progressed in many parts of the world, cannabis companies have been working feverishly to expand and gain first-mover advantages in many emerging markets, could expanding into Europe this early be a mistake?

When U.S. lawmakers passed the farm bill back in December which legalized cannabidiol (CBD) derived from hemp, they likely overlooked the problems that might stem from it. Not only does it cause confusion among consumers, but for authorities, telling the difference between hemp or illegal marijuana has become a big issue.

We've seen a lot of wheeling and dealing in Canada when it comes to cannabis companies, but U.S. companies are getting in on the action as well. Cresco Labs (CSE:CL)(OTCQX:CRLBF) announced in a release today that it would be purchasing Origin House (CSE:OH)(OTCQX:ORHOF) in an all-stock deal valued at CAD $1.1 billion.

Jelly Belly candies now has 38 new flavours that are infused with cannabidiol (CBD). Although the public has only recently learned about the new candies, Jelly Belly's founder David Klein says that they're already sold out. With a patent-pending formula that took two and a half years, it could be the next big thing in the edibles market.

Monday was supposed to be a big day for New Jersey in the bid to move marijuana legalization forward. However, that wasn't the case as a vote on a bill that was set to legalize recreational marijuana was called off as there was not enough support from the State's Senate.

With all the excitement surrounding the industry's growth, many companies have been popping up in the hopes of gaining market share. And that's left novice investors with too many options to choose from. If you're interested in investing in cannabis, a new US marijuana ETF is coming.

As the cannabis industry continues to grow, so too does the demand for jobs. According to a report done by Leafly, which collects data on the cannabis industry, nearly 65,000 full-time jobs were created in the industry in 2018. And that number is only going to grow...

With cannabis edibles, extracts, and topicals expected to be legal in Canada later this year, we take a look at some of the biggest names in cannabis extraction.

Tilray, Inc (NASDAQ:TLRY) released its Q4 and full-year results on Monday. Here's a look at how it performed.

Even though marijuana may be permitted in one jurisdiction, it could still remain illegal in another. New York, for example, is looking at legalizing marijuana as Governor Cuomo has expressed an interest in doing so. The problem is that under Cuomo's plan, large cities and all counties would be able to decide whether they want to allow recreational marijuana or not.

With North America expected to become the largest cannabis market in the world, we examine some of the fastest growing cannabis retailers preparing to dominate this market.

MedMen Enterprises Inc (CSE:MMEN) released its year-end results at the end of February and while sales were good, it was still nowhere near profitable. During the second quarter, The Company recorded sales of nearly $30 million, which is almost 10 times the amount that it posted a year ago. For the past six months, revenues reached $51 million compared to $5 million in 2017.

Marijuana legalization has been progressing through many U.S. States and as many as 10 have legalized it for recreational use thus far. However, federal laws remain unchanged and that's the industry's biggest impediment today. Without being able to transport cannabis across State lines it's inefficient for companies to operate unless they are confined to just one location.

It's not hard to find anecdotes of how CBD has helped provide patients with pain relief, normally after exhausting all other options. The problem, however, is that there isn't a lot of data behind those claims and finding hard facts and numbers on the effectiveness of CBD is very difficult.

An investment bank out of New York thinks that in a decade the cannabis industry could grow to be $130 billion. Jeffries Group, the company behind the estimate, is relying on assumptions that we'll see legalization progress around the world.

Medical marijuana has been generating a lot of interest around the world for its ability to treat many different diseases and ailments. A recent study out of Penn State College also suggests that it could it could be used to treat cancer cells as well.